First-line Therapy

First-line therapy is the initial, preferred treatment a doctor recommends for a newly diagnosed disease based on the strongest available evidence that it works for most patients with that condition. If first-line therapy stops working or cannot be tolerated, doctors move to second-line and later treatments. For mesothelioma, first-line therapy typically refers to the first systemic treatment given after diagnosis, sometimes combined with surgery or radiation.

Origin

The phrase comes from twentieth-century clinical oncology and infectious disease practice, where treatments came to be ranked in lines or tiers based on evidence of effectiveness, side effects, and sequencing. The concept became formalized in cancer care through national treatment guidelines such as those issued by the National Comprehensive Cancer Network (NCCN).

Significance in Asbestos Context

For people diagnosed with pleural mesothelioma, first-line therapy has historically been chemotherapy with pemetrexed plus cisplatin (or carboplatin), often with bevacizumab added. Since 2020, the FDA-approved combination of immunotherapy drugs nivolumab plus ipilimumab has become a first-line option, especially for non-epithelioid subtypes, and chemo-immunotherapy combinations are also used. Knowing what counts as first-line matters because it determines insurance coverage, eligibility for clinical trials (many trials require you to have failed or be ineligible for standard first-line treatment), and what your oncologist will recommend at diagnosis. The specific first-line regimen chosen can also become relevant in a legal claim, because treatment costs, side effects, and response are documented as part of damages.

Example Sentence

After her mesothelioma diagnosis, the oncologist explained that first-line therapy would be a combination of nivolumab and ipilimumab given every few weeks at the cancer center.

Related Terms

Pemetrexed, Cisplatin, Immunotherapy, Second-line Therapy, Clinical Trial, Multimodal Therapy

Notes

• Ask your oncologist specifically which first-line regimen they recommend and why. Options now include chemotherapy, immunotherapy, or combinations, and the best choice often depends on the mesothelioma subtype (epithelioid vs. sarcomatoid/biphasic).
• Ask whether you are eligible for a clinical trial as first-line treatment before starting standard therapy; once you begin treatment, some trials are no longer open to you.
• Keep copies of all treatment records, infusion schedules, and bills. These document both your medical course and your economic damages if you pursue a legal claim.
• Confirm that your treatment is being directed by an oncologist with mesothelioma experience or at a specialty center; first-line choices have changed significantly in recent years.